| 1 | EpicHeart For Advanced Heart Failure | 2019-017-S |  |
| 2 | Brolucizumab (RTH258) For Neovascular Age-Related Macular Degeneration (NAMD) | 2019-016-S | |
| 3 | Unpowered Ankle Exoskeleton | 2019-015-S | |
| 4 | ENTRECTINIB for Neurotrophic Tropomyosin Receptor Kinase (NTRK) Fusion-Positive, Locally Advanced Or Metastatic Solid Tumours_ And Metastatic, ROS1-Positive Non-Small Cell Lung Cancer (NSCLC) | 2019-014-S | |
| 5 | S5 DNA Methylation Classifier (Epigenetic-Based Test) For Cervical Cancer Screening | 2019-011-S | |
| 6 | Percepta Bronchial Genomic Sequencing Classifier For Lung Cancer Screening | 2019-010-S | |
| 7 | Iclaprim for Acute Bacterial Skin and Skin Structure Infections | 2019-007-S | |
| 8 | Diroximel Fumarate (ALKS 8700 BIIB0998) For Relapsing-Remitting Multiple Sclerosis | 2019-006-S | |
| 9 | NEUVAX™ (Nelipepimut-S, NP-S) For Recurrence Breast Cancer | 2019-006-B | |
| 10 | BILISPEC | 2019-005-S | |
| 11 | Targeted Low Dose Radiotherapy For Early Breast Carcinoma Post Breast-Conserving Surgery | 2019-004-B | |
| 12 | Quizartinib For Treatment Of Patients With Relapsed/Refractory Fms-Like Tyrosine Kinase 3 (FLT3)-Internal Tandem Duplication (ITD) Acute Myeloid Leukaemia (AML) | 2019-003-S | |
| 13 | EZ Weigh | 2019-003-B | |
| 14 | Adjunctive Tecentriq In PD-L1-Positive Unresectable Locally Advanced Or Metastatic Triple-Negative Breast Cancer | 2019-002-S | |
| 15 | INVOSSATM for Moderate Knee Osteoarthritis | 2019-001-S | |
| 16 | Intranasal Esketamine | 2019-001-B | |
| 17 | Odon Device | 2018-011-S | |
| 18 | Epidiolex | 2018-010-S | |
| 19 | Extemporaneous Mixer (E-MIX) | 2018-008-S | |
| 20 | AerSLEEP | 2018-008-S | |
| 21 | CANCERSEEK | 2018-006-S | |
| 22 | SOTAGLIFOZIN FOR TYPE 1 DM | 2018-004-S | |
| 23 | IMEGLIMIN FOR TYPE 2 DM | 2018-003-S | |
| 24 | IDX-DR FOR SCREENING OF DIABETIC RETINOPATHY IN PRIMARY HEALTH CLINIC | 2018-001-S | |
| 25 | RITUXIMAB BIOSIMILARS | 2018-001-B | |
.png)
